Modulation of Apoptosis by Natural Products for Cancer Therapy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Natural products can exhibit many beneficial effects on human health. As far as cancer is concerned, naturally occurring compounds have been reported to prevent tumorigenesis and also to suppress the growth of established tumors. As cancer cells have evolved multiple mechanisms to resist the induction of programmed cell death (apoptosis), the modulation of apoptosis signaling pathways by natural compounds has been demonstrated to constitute a key event in these antitumor activities. This review presents some examples of how apoptosis pathways are targeted by selected naturally occurring agents and how these events can be exploited for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 4×
“The sustained opening of the PTPC coupled with the loss of interactions with HK favors the loss of the mitochondrial membrane potential leading to an osmotic imbalance and swelling of the mitochondrial matrix, a phenomenon called mitochondrial permeability transition (MPT) [10].”
BackgroundInfluentialExtrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312 · cited 1×
“Two major apoptosis pathways, i.e., the receptor (extrinsic) pathway and the mitochondrial (intrinsic) pathway, eventually result in the activation of caspases, a family of enzymes that act as death effector molecules in various forms of cell death [5,6].”
BackgroundSelf-citationThe Bcl-2 apoptotic switch in cancer development and therapy
Adams, J. M., & Cory, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210220 · Cited by 2,176 · cited 5×
“The anti-apoptotic Bcl-2 family members comprise, e.g., Bcl-2, Bcl-XL and Mcl-1, while the multidomain proteins Bax and Bak and BH3 do-main-only proteins such as Bid, Bim, Noxa and Puma belong to the pro-apoptotic molecules [9].”
BackgroundInfluentialRas, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
Toxic proteins released from mitochondria in cell death
Saelens, X., Festjens, N., Walle, L. V., Gurp, M. V., Loo, G. V., & Vandenabeele, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207523 · Cited by 986 · cited 3×
“…tochondrial intermembrane space proteins such as cytochrome c or second mitochondria-derived activator of caspase (Smac)/direct IAP binding protein with low pI (DIABLO) into the cytosol triggers a common prefinal stage of apoptosis that is characterized by the activation of effector caspases [11].”
BackgroundInfluentialSuperoxide dismutase as a target for the selective killing of cancer cells
Huang, P., Feng, L., Oldham, E. A., Keating, M. J., & Plunkett, W. (2000) · Nature · doi:10.1038/35030140 · Cited by 842
Natural compounds for cancer treatment and prevention
Nobili, S., Lippi, D., Witort, E., Donnini, M., Bausi, L., Mini, E., & Capaccioli, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.017 · Cited by 780 · cited 1×
“Over the last decades, natural compounds have attracted considerable attention as cancer chemopreventive agents and also as cancer therapeutics [1].”
BackgroundTriterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637 · cited 1×
“Betulinic acid [3 β -hydroxy-lup-20(29)-en-28-oic acid] is a pen-tacyclic triterpenoid, which naturally occurs, for example, in the bark of white birch trees and has been identified to stimulate the mitochondrial apoptosis pathway preferentially in cancer cells [14 – 16].”
BackgroundThe CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628 · cited 1×
“Once activated, caspase-8 either directly cleaves and thereby activates effector caspase-3 or alternatively, cleaves Bid into tBid [8,9].”
BackgroundFulda, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24064 · Cited by 615
Self-citationSelective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Zuco, V., Supino, R., Righetti, S. C., Cleris, L., Marchesi, E., Gambacorti-Passerini, C., & Formelli, F. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00718-2 · Cited by 530 · cited 1×
“Betu-linic acid was also reported in various models to induce apoptosis in a p53-independent fashion, including chemotherapy-refactory cases [15,19 – 24], indicating that betulinic acid may bypass some types of drug resistance.”
ResultIAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524 · cited 1×
“IAP proteins are a family of endogenous caspase inhibitors and comprise eight human analogues, including XIAP, c-IAP1, c-IAP2, survivin and livin/mel-anoma-IAP (ML ‑ IAP) [12].”
BackgroundTargeting the extrinsic apoptosis pathway in cancer
Ashkenazi, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.001 · Cited by 418
Kitada, S., Leone, M., Sareth, S., Zhai, D., Reed, J. C., & Pellecchia, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030190z · Cited by 379
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 369
Self-citationFulda, S., Friesen, C., Łoś, M., Scaffidi, C., Mier, W., Benedict, M., Núñez, G., Krammer, P. H., Peter, M. E., & Debatin, K. (1997) · PubMed · Cited by 342
Self-citationHypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298
Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
Constantinou, C., Papas, A., & Constantinou, A. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23689 · Cited by 281
Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.
Fulda, S., Susín, S. A., Kroemer, G., & Debatin, K. (1998) · PubMed · Cited by 261
Self-citationFulda, S., & Debatin, K.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1656 · Cited by 250
Self-citationMethyl jasmonate binds to and detaches mitochondria-bound hexokinase
Goldin, N., Arzoine, L., Heyfets, A., Israelson, A., Zaslavsky, Z., Bravman, T., Bronner, V, Notcovich, A., Shoshan-Barmatz, V, & Flescher, E. (2008) · Oncogene · doi:10.1038/onc.2008.108 · Cited by 208
Cell death in health and disease
Lockshin, R. A., & Zakeri, Z. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00150.x · Cited by 200
Belzacq, A.-S., El Hamel, C., Vieira, H. L. A., Cohen, I., Haouzi, D., Métivier, D., Marchetti, P., Brenner, C., & Kroemer, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204953 · Cited by 194
Liu, G., Kelly, W. K., Wilding, G., Leopold, L., Brill, K., & Somer, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2985 · Cited by 181
Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors
Fulda, S., & Debatin, K. (2000) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20001201)35:6<616::aid-mpo27>3.0.co;2-n · Cited by 158
Self-citationWick, W., Grimmel, C., Wagenknecht, B., Dichgans, J., & Weller, M. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38274-6 · Cited by 144
Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells
André, N., Carré, M., Brasseur, G., Pourroy, B., Kovacic, H., Briand, C. M., & Braguer, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03691-8 · Cited by 138 · cited 1×
“In a cell-free system, betulinic acid has been demonstrated to directly cause mitochondrial outer membrane perme-abilization and cytochrome c release in a Bcl-2 or Bcl-X L -depen- dent manner, yet independently of caspases [14,15,17,18].”
BackgroundXiao, D., Lew, K. L., Zeng, Y., Xiao, H., Marynowski, S. W., Dhir, R., & Singh, S. V. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl087 · Cited by 133
Non‐peptidic small molecule inhibitors against Bcl‐2 for cancer therapy
Azmi, A. S., & Mohammad, R. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21567 · Cited by 119 · cited 1×
“1 ), a polyphenolic aldehyde that naturally occurs in the cotton plant [41], has been demonstrated to simultaneously antagonize several anti-apoptotic Bcl-2 proteins, which interfere with mitochondrial outer membrane permeabilization, including Bcl-2, Bcl-X L , Bcl-W and Mcl-1 [42].”
BackgroundDevelopment of mitochondria-targeted derivatives of resveratrol
Biasutto, L., Mattarei, A., Marotta, E., Bradaschia, A., Nicola Sassi, A., Garbisa, S., Zoratti, M., & Paradisi, C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.100 · Cited by 115 · cited 2×
“To improve the targeting to mitochondria, resveratrol has been coupled to the membrane-permeant lipo-philic TPP cation [33].”
BackgroundMethodKitada, S., Kress, C. L., Krajewska, M., Jia, L., Pellecchia, M., & Reed, J. C. (2008) · Blood · doi:10.1182/blood-2007-09-113647 · Cited by 112
Dong, L.-F., Swettenham, E., Eliasson, J., Wang, X.-F., Gold, M., Medunic, Y., Stantic, M., Low, P., Prochazka, L., Witting, P. K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3034 · Cited by 102 · cited 2×
“…with both ubiquinone-binding sites of the respiratory complex II, leading to the displacement of ubiquinone from complex II and subsequently to ROS generation [35]. α ‑ TOS not only targets cancer cells but also endothelial cells [36], which may contribute to its potent antitumor activity.”
BackgroundSalti, G. I., Kichina, J. V., Gupta, T. K. D., Shahab Uddin, M. S., Bratescu, L., Pezzuto, J. M., Mehta, R. G., & Constantinou, A. I. (2001) · Melanoma Research · doi:10.1097/00008390-200104000-00003 · Cited by 41
Cited by
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I., & Mahmod, A. I. (2021) · Biomedicines · doi:10.3390/biomedicines9101353 · Cited by 231
Molecular targets of curcumin for cancer therapy: an updated review
Kasi, P. D., Tamilselvam, R., Skalicka-Woźniak, K., Nabavi, S. F., Daglia, M., Bishayee, A., Pazoki-toroudi, H., & Nabavi, S. M. (2016) · Tumor Biology · doi:10.1007/s13277-016-5183-y · Cited by 216
Molecular mechanisms underlying anticancer effects of myricetin
Devi, K. P., Rajavel, T., Habtemariam, S., Nabavi, S. F., & Nabavi, S. M. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.10.004 · Cited by 159
Metadata
- Authors
- Fulda, S.
- Venue
- Planta Medica
- Publisher
- Georg Thieme Verlag KG
- Published
- 2010-05-19
- Volume
- 76
- Issue
- 11
- Pages
- 1075-1079
- ISSN
- 0032-0943 (ISSN-L)
- 1439-0221
- OpenAlex
- W1974583613
- Cited by
- 211
- References
- 34
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.